期刊文献+

登革病毒样颗粒研究概况

Progress in researches on dengue virus-like particles
下载PDF
导出
摘要 病毒样颗粒(virus-like particles,VLPs)是不含病毒特异核酸的空壳结构,许多病毒结构蛋白都具有自动组装成VLPs的能力,在形态结构上与天然的病毒颗粒相似,具有很强的免疫原性和生物学活性。登革病毒(Dengue virus,DV)为黄病毒属的一员,伊蚊为其传播媒介,流行地域广泛,影响人口众多,所致疾病复杂,发病率高,目前尚缺乏有效的治疗手段和预防措施。文中对DV的组装与成熟,VLPs的产生、影响DV的VLPs产生因素,以及在研制疫苗或佐剂等方面的应用前景做一综述。 Virus-like particles (VLPs) are particles without virus-specific genetic materials. Many structure proteins of virus have the ability to assemble into virus-like particles, which are similar in structure to those of natural viruses, and can stimulate strong immunoresp0nse in the host. Dengue viruses ( DVs), the genus of Flavivirus, are transmitted to humans through the bites of infected Aedes mosquitoes, prevail in many areas and have infected many people, causing a wide range of complicated diseases. For dengue diseases, however, there are still no effective preventive and therapeutic measures. This article focuses on the assembly and maturation of DVs, the production of VLPs and its influencing factors, and the prospect of the development and application of dengue VLP-related vaccines and adjuvants.
出处 《医学研究生学报》 CAS 北大核心 2012年第7期762-766,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(31070811) 重庆市自然科学基金(CSTC 2009BB5015)
关键词 登革病毒 病毒样颗粒 疫苗 佐剂 抗原 Dengue virus Virus-like particle Vaccine Adjutant Antigen
  • 相关文献

参考文献35

  • 1Kuhn ILl, Zhang W, Rossmann MG, et al. Structure of dengue virus : Implications for flavivirus organization, maturation, and fu- sion[J]. Cell, 2002, 108(5):717-725.
  • 2Lopez C, Gil L, Lazo L, et al. In vitro assembly of nucleocapsid- like particles from purified recombinant capsid protein of dengue- 2 virus[J]. Arch Virol, 2009,154(4) :695-698.
  • 3Murgue B. Severe dengue:questioning the paradigm [ J]. Mi- crobes Infect, 2010, 12(2) :113-118.
  • 4Kanakaratne N, Wahala WM, Messer WB, et al. Severe dengue epidemics in Sri Lanka, 2003-2006 [J]. Emerg Infect Dis, 2009, 15(2) :192-199.
  • 5Ross TM. Dengue Virus[J]. Clin Lab Med, 2010, 30( 1 ) :149- 160.
  • 6Gil L, Lopez C, Lazo L, et al. Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CIM and CD8 cells against viral encephalitis in mice [ J ]. Int Immuno, 2009, 21 (10) :1175-1183.
  • 7Warfield KL, Bosio CM, Welcher BC, et al. Ebola virus-like particles protect from lethal Ebola virus infection [ J ]. Proc Natl Acad Sci USA, 2003, 100(26) :15889-15894.
  • 8Pearton M, Kang SM, Song JM, et al. Changes in human 1anger- hans cells following intradermal injection of influenza virus-like particle vaccines[J]. PLoS One, 2010, 5(8) :1-10.
  • 9Frazer IH, Quinn M, Nicklin JL, et al. Phase 1 study of HPV16- specific immunotherapy with E6E7 fusion protein and ISCOMA- TRIX adjuvant in women with cervical intraepithelial neoplasia [J]. Vaccine, 2004, 23(2) :172-181.
  • 10Nardin EH, Oliveira GA, Calvo-Calle JM, et al. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes [ J ]. Infect Immun, 2004, 72 ( 11 ) : 6519-6527.

二级参考文献28

  • 1王鲁平.人乳头状瘤病毒感染与子宫颈病变关系的研究进展及应对策略[J].诊断病理学杂志,2007,14(2):86-89. 被引量:47
  • 2Shinde V, Bridges CB, Uyeki TM, et al. Triple-Reassortant Swine Influenza A (H!) in Humans in the United States, 2005- 2009[J]. N Engl J Med, 2009,360(25) :2616-2625.
  • 3Fatimah S,Jain S,Finelli L, et al. Emergence of a Novel SwineOrigin Influenza A (H1NI) Virus in Humans[J1. N Engl J Med, 2009,360(25) :2605-2615.
  • 4Trifonov V, Khiabanian H, Greenbaum B, et al. The origin of the recent swine infuenza A( H1N1 ) virus infecting human[J].Euro Surveill, 2009 30,14(17) ,19193.
  • 5Garten RJ, Davis CT, Russell CA, et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A( H1 N1 ) Influenza Viruses Circulating in Humans [ J ]. Science, 2009,325 ( 5937 ) : 197- 201.
  • 6Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5NI (HK/97) and 1918 influenza A viruses contributes to increased virulence [ J ]. PLoS Pathog, 2007,3 (10) :1414-1421.
  • 7Steel J, Lowen AC, Mubareka S, et al. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N[ J]. PLoS Pathog, 2009,5( 1 ) :e1000252.
  • 8Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice [J]. J Virol, 2006,80(16) :7976-7983.
  • 9Jackson D, Hossain M J, Hickman D, et al. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity [J]. Proc Natl Acad Sci USA, 2008,105 ( 11 ) :4381-4386.
  • 10Lau SK, Chan KH, Yip CC, et al. Confirmation of the first Hong Kong case of human infection by novel swine-origin influenza A ( H1 N1 ) virus using ultra-rapid & real-time RT-PCR [ J ]. Clin Microbio1,2009,47 ( 7 ) :2344-2346.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部